277 related articles for article (PubMed ID: 30835716)
1. Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence.
Shen T; Li H; Song Y; Li L; Lin J; Wei G; Ni T
Aging (Albany NY); 2019 Mar; 11(5):1356-1388. PubMed ID: 30835716
[TBL] [Abstract][Full Text] [Related]
2. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
Schwich OD; Blümel N; Keller M; Wegener M; Setty ST; Brunstein ME; Poser I; Mozos IRL; Suess B; Münch C; McNicoll F; Zarnack K; Müller-McNicoll M
Genome Biol; 2021 Mar; 22(1):82. PubMed ID: 33706811
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
5. HNRNPA1-mediated 3' UTR length changes of
Jia Q; Nie H; Yu P; Xie B; Wang C; Yang F; Wei G; Ni T
Aging (Albany NY); 2019 Jun; 11(13):4407-4437. PubMed ID: 31257225
[TBL] [Abstract][Full Text] [Related]
6. 3' UTR lengthening as a novel mechanism in regulating cellular senescence.
Chen M; Lyu G; Han M; Nie H; Shen T; Chen W; Niu Y; Song Y; Li X; Li H; Chen X; Wang Z; Xia Z; Li W; Tian XL; Ding C; Gu J; Zheng Y; Liu X; Hu J; Wei G; Tao W; Ni T
Genome Res; 2018 Feb; 28(3):285-94. PubMed ID: 29440281
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF3 represses translation of p21
Kim J; Park RY; Kee Y; Jeong S; Ohn T
Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491
[TBL] [Abstract][Full Text] [Related]
8. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
[TBL] [Abstract][Full Text] [Related]
9. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
10. Tempo-spatial alternative polyadenylation analysis reveals that 3' UTR lengthening of Mdm2 regulates p53 expression and cellular senescence in aged rat testis.
Wang L; Chen M; Fu H; Ni T; Wei G
Biochem Biophys Res Commun; 2020 Mar; 523(4):1046-1052. PubMed ID: 31973811
[TBL] [Abstract][Full Text] [Related]
11. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
12. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.
Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E
Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
14. Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression.
Zhou L; Guo J; Jia R
Biochem Biophys Res Commun; 2019 Feb; 509(4):966-972. PubMed ID: 30654935
[TBL] [Abstract][Full Text] [Related]
15. Antisense transcription regulates the expression of sense gene via alternative polyadenylation.
Shen T; Li H; Song Y; Yao J; Han M; Yu M; Wei G; Ni T
Protein Cell; 2018 Jun; 9(6):540-552. PubMed ID: 29273853
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic SRSF3 in health and diseases.
Jia R; Zheng ZM
Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
[TBL] [Abstract][Full Text] [Related]
17. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
18. SRSF3 promotes pluripotency through
Ratnadiwakara M; Archer SK; Dent CI; Ruiz De Los Mozos I; Beilharz TH; Knaupp AS; Nefzger CM; Polo JM; Anko ML
Elife; 2018 May; 7():. PubMed ID: 29741478
[TBL] [Abstract][Full Text] [Related]
19. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells.
Kurokawa K; Akaike Y; Masuda K; Kuwano Y; Nishida K; Yamagishi N; Kajita K; Tanahashi T; Rokutan K
Oncogene; 2014 Mar; 33(11):1407-17. PubMed ID: 23503458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
